Thomson Medical – Limited Impact from Proposed Distribution of RE Business. Still Looks Expensive.
349 Views12 Nov 2018 14:07
Thomson Medical Group f.k.a. Rowsley Ltd (ROWS SP) (“TMG”), a SGX-listed healthcare and property developer, announced this morning that it plans to...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 27-minute read)
Discussions
(Paid Plans Only)
Royston Foo
Singapore and emerging market real estate
Price Chart(Sign Up to Access)
- Parkway Pantai: Good Brand with Limited Upside03 Aug 2020
- Jubilant Pharma: Good Drugs, Fully-Valued Bonds26 Jun 2020
- Thomson Medical Group: Medicated by Leverage22 May 2020
- Thomson Medical – Limited Impact from Proposed Distribution of RE Business. Still Looks Expensive.12 Nov 2018
- Signs of Irrational Exuberance as Rowsley Transforms into Thomson Medical19 Dec 2017
x